Note 8 - Subsequent Events

9 Months Ended

12 Months Ended

Sep. 30, 2020

Dec. 31, 2019

Notes to Financial Statements

Subsequent Events [Text Block]

Note

8.

Subsequent Events

None.

Note

10.

Subsequent Events 

In

January 2020,

pursuant to the terms of an inducement offer, certain holders of

5,555,554

of our common stock purchase warrants exercised their warrants at an exercise price of

$1.36

per share generating approximately

$7.6

million of gross proceeds. See Note

4

for additional details over this transaction.

On

March 23, 2020,

in order to provide the Company with flexibility in inducing new employees, the Board of Directors approved an amendment to the Company's Inducement Award Stock Option Plan, increasing the number of shares authorized under the plan by

500,000

for an aggregate total of

715,000

shares.

In

December 2019

an outbreak of a novel strain of coronavirus originated in Wuhan, China, and has since spread around the world, including to the United States. This outbreak has already resulted in extended shutdowns of many businesses around the world, including in the United States. We cannot presently predict the scope, severity and longevity of any potential business shutdowns or disruptions, but business or economic disruptions as are now being experienced, could adversely affect our ongoing or planned research and development activities as well as the execution of our acquisition and/or in-licensing strategy.